Measurable residual disease-negative remission of BRAF-V600Emutated acute myeloid leukemia with dabrafenib and trametinib. (PubMed, Haematologica) - Oct 2, 2026 - "Not available."
Journal • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology • BRAF
|
|
Annalen Bleckmann; Britta Heptner; Christian Reicherts; Christine Eisfeld; Christoph Schliemann; Georg Lenz; Jan-Henrik Mikesch; Julia Marx; Klaus Wethmar; Laura Polmann; Lisa M Sgonina; Matthias Stelljes
|